Annual Costs of Dementia Care Exceed GDP, New Report Says
If dementia care were a company, it would be the world’s largest in terms of annual revenue, surpassing even Wal-Mart.
addex pharmaceuticals
Drug Compliance a Major Issue for Psych Patients
Compliance is a vital part of managing mental health issues, considering the widespread use of psychiatric medications in the U.S.
FDA Approves First Monthly Atypical Antipsychotic for Schizophrenia
The U.S. Food and Drug Administration has approved Janssen Pharmaceuticals’ Invega Sustenna for acute and maintenance treatment of schizophrenia.
FDA Approves Fanapt for Schizophrenia Patients
Maryland-based Vanda Pharmaceuticals announced that the U.S. Food and Drug Administration has approved Fanapt (otherwise known as iloperidone) for the acute treatment of adult patients with schizophrenia.